CombiMatrix Company

CombiMatrix develops proprietary technologies, products and services for drug development, genetic analysis, molecular diagnostics and more.

Founded Date: 1995
Investor Type: N/A
Employee Number: 51-100
Investment Stage: N/A
Funding Status: M&A
Number Of Exists: N/A
Technology: Cancer
Industry: PharmTech
Headquarters: Irvine, California, United States
Estimated Revenue: $10M to $50M